Pallas Health Review: Is It Legit?

Pallas Health is a telehealth platform run by Brentmoor, Inc. It connects you with US-licensed clinicians who can prescribe a GLP-1 when it is clinically appropriate.

Here is how it goes. You fill in a short online intake. A licensed provider reviews your health history before prescribing. If a GLP-1 fits, you are charged once the clinician prescribes. The drug ships free and discreetly from a US-licensed pharmacy, and refills continue on the same plan.

The menu is wide. On the compounded side there is semaglutide as a weekly injection or a daily tablet, and tirzepatide as an injection. On the brand-name side there are Wegovy as a pen or a pill, Foundayo, Zepbound, Ozempic and Mounjaro. Your clinician decides which one fits you.

Pallas does not make or compound any drug itself. Compounded drugs come from US-licensed compounding pharmacies and may look different from the products on the site. To understand the drugs themselves, read our pages on semaglutide and tirzepatide. Pallas serves all 50 states and Washington, D.C.

Mostly yes. Pallas is a real telehealth platform with a named company behind it, Brentmoor, Inc., a named clinical partner, Lion MD, and no FDA warning letter. The gap is the pharmacy: Pallas names none of the pharmacies that make its compounded drugs.

Pallas says its compounded drugs come from US-licensed compounding pharmacies. It says they are either pharmacies that fill a prescription for one named patient, or larger outsourcing facilities that register with the FDA. With no names, there is nothing to match against the FDA register we read.

The rest is clear. The site says plainly which drugs are compounded and which are FDA-approved brand-name products. Pallas shows no LegitScript badge. Ask for the pharmacy name before your first order.

Compounded semaglutide costs $199 every 4 weeks after a $139 first month, with the drug, the clinician and shipping included. There is no other fee.

The compounded plans bill every 12 weeks. Semaglutide is $597 every 12 weeks, and $139 is only the first-month price. Tirzepatide is $897 every 12 weeks, which is $299 every 4 weeks after a $179 first month. Both cost the same at every dose, from your starting dose to maintenance. The annual plan is lower: $139 a month on average for semaglutide and $239 for tirzepatide.

The brand-name drugs are cash-pay. Wegovy is $1,349 a month for a 28-day supply. Ozempic is $1,299 a month. Zepbound is $1,069 a month. These prices reflect pharmacy cash rates and may change.

There is no membership fee, no per-visit charge and no shipping fee. Pallas does not bill insurance. Three months of compounded semaglutide at the standing rate total $597, with no fees added.

Pallas ranks 7 of the 15 programs in its group on a 3-month plan, its shortest compounded term. The median there is $199 a month. For scale, a pharmacy pays $871.12 for a Wegovy 1.7 mg pen package, effective September 23, 2026. That is an acquisition cost, not what a patient pays.

The care starts with an online intake, not a video call. A clinician reviews it, and a care team you message handles follow-ups. In Arkansas, Mississippi, New Mexico, North Dakota, Rhode Island, South Dakota, West Virginia and DC, you need one video visit.

The clinicians come from Lion MD, a nationwide team of US-licensed professionals. Pallas uses CareValidate to check their licenses and coordinate dispensing. Each prescriber "exercises independent clinical judgment, and may decline to prescribe when treatment is not clinically appropriate."

Pallas does not state how fast a clinician reviews your intake, or whether you need labs. Ask both before you pay. One app page refused our automated read, which limits our view of the logged-in portal.

Pallas Health has no FDA warning letter and no open flag on its record. Its record is clean. There is nothing against a pharmacy either, because none is named.

The safety question with a compounded program is the drug itself. A compounded GLP-1 is made by a pharmacy, and the FDA does not review it the way it reviews Wegovy or Zepbound. The brand-name drugs on Pallas are the FDA-approved products, shipped from a US-licensed pharmacy.

Pallas says "GLP-1 medications are not appropriate for everyone." For side effects, doses and who should not take these drugs, read our semaglutide and tirzepatide pages, which quote the FDA labels.

You can cancel any plan at any time. The catch is timing. Once your prescription is issued, the current billing cycle is not prorated or refunded. So cancel before the next cycle starts, not during it.

If a clinician does not approve you, you get a full refund. Pallas also offers a money-back promise at 6 months, with conditions. You need six continuous paid months, doses and check-ins on schedule, and a logged start and six-month weight. You must ask within 30 days of the six-month mark.

The trap is to count on that promise without logging your weight from day one.

These are the reviews Pallas publishes on its own site, and there are only three of them on the pages we read. One praises a provider who explained every option and let the patient decide. The other two are about how people felt day to day: steadier, more motivated, refreshed.

None of them talks about the price, the shipping or the cancel rules. They are the brand's own published reviews, and this site collects no independent reviews. Read them as three people's experience, as the brand chose to show it. Read the prices and terms above for what you will pay and what you sign.

Price transparency scores 9.66 at a 20% weight: every price is public, but two first-month prices changed on re-read. Cost and value scores 6 at a 15% weight: rank 7 of 15 on a 3-month plan. Traceability scores 7.2 at a 15% weight: the pharmacy type is stated, the names are not. Clinical care scores 7.2 at a 15% weight: a named clinical partner, no stated wait time or lab policy.

Safety scores 8.75 at a 20% weight: no letter, no flag, but no LegitScript badge. Terms score 9.5 at a 10% weight: cancel anytime, but a cycle in progress is not refunded. Availability scores 10 at a 5% weight: all 50 states, DC and free shipping.

No dimension moved since our last check. Several pages changed, but the facts behind each score held. The weights are on our methodology page.